Pharmacy Consulting

Pharmacy Healthcare Solutions LLC (PHSL) consults with pharmaceutical manufacturers, PBMs, pharmacies (retail, specialty, mail service, LTC, and hospital outpatient), and technology companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSL with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

Learn More About PHSL Services

News & Events

NCPDP recognized PHSL Senior Consultant Dave Schuetz

Congratulations to PHSL Senior Consultant Dave Schuetz for being recognized by NCPDP as Most Valuable Participant (MVP) for dedication as a task group leader for the WG2 Product Review and Billing Unit Exception Task Group at the February 2024 Work Group meeting.  Thanks for all of your efforts and leadership!   Posted: February 2024

PHSL to Attend AMCP 2024 Annual Conference

PHSL President Ann Johnson and Director of Business Development Karlo Zovko will be attending the AMCP Annual Meeting on April 16-18 in New Orleans, LA.  AMCP expects to bring together over 4,000 industry leaders, health care professionals, and stakeholders for opportunities to network and attend sessions on trending topics. Contact PHSL if you would like Read More →

Medicare Prescription Payment Plan…aka OOP Price Smoothing presented at ASAP by Ann Johnson

PHSL President Ann Johnson presented at the American Society for Automation in Pharmacy (ASAP) 2024 Annual Conference. Ann’s presentation discussed the Inflation Reduction Act’s “price smoothing” provision, including implications for patients, payers, and pharmacies. Click here to view Ann’s presentation slides.

Latest from the Blog

OTC Oral Contraceptive Coming in 2024

Oral contraceptives are a safe, affordable, and effective way of preventing pregnancy. In July 2023, the FDA approved Opill (norgestrel) tablet, the first daily oral contraceptive that will be available for sale in the United States without a prescription. Opill is a new option for individuals who do not have access to a physician and Read More →

Gene Therapy Challenges and Compendia Implications

Gene therapy is an emerging topic in the medical field with new innovations and successes documented daily. The FDA shared their prediction that, based on the current pipeline, they expect to approve anywhere from 10-20 gene and cellular therapy products each year beginning in 2025. Gene therapy works by replacing a disease-causing gene, inactivating genes Read More →

FDA NDC Final Rule Timing

Patricia Milazzo, RPh and Dave Schuetz, RPh, Senior Consultants at PHSL, wrote an article featured in the Viewpoint column of the September/October 2022 edition of ComputerTalk for the Pharmacist.  Their article focuses on the FDA’s plans for the National Drug Code (NDC).  At the time the article was published, the authors expected the FDA would Read More →